Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Industry News

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

November 02, 2016

News Industry News

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

October 03, 2016

News Industry News

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

September 01, 2016

News Industry News

AtriCure Receives CE Mark for the AtriClip® PRO2 Device

June 29, 2016

News Industry News

SentreHEART Receives 510k Approval for the LARIAT XT Suture Delivery Device

May 06, 2016

News Industry News

Tips for Convincing Your Boss to Attend TCT 2016

April 13, 2016

News Industry News

AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib

February 17, 2016

News Industry News

AtriCure Announces Approval for the AtriClip in Japan

January 19, 2016

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

News Industry News

SentreHEART Receives CE Mark Approval for the LARIAT Surgical Left Atrial Appendage Suture Delivery Device

October 08, 2015

News Industry News

ACC prepares to launch two afib-related registry programs

August 14, 2015

News Industry News

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

June 29, 2015

News Industry News

Good Samaritan Hospital Offers an Alternative to Long-Term Warfarin Medication for Atrial Fibrillation with Newly Approved Watchman™ LAAC Implant

May 18, 2015

News Industry News

University of Michigan Health System among first in nation to use new device for stroke prevention

May 15, 2015

News Industry News

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

March 24, 2015

News Industry News

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

October 08, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

Advertisement

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

AtriCure Receives CE Mark for the AtriClip® PRO2 Device

SentreHEART Receives 510k Approval for the LARIAT XT Suture Delivery Device

Tips for Convincing Your Boss to Attend TCT 2016

AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib

AtriCure Announces Approval for the AtriClip in Japan

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Scripps experts present at 2015 TCT scientific symposium

SentreHEART Receives CE Mark Approval for the LARIAT Surgical Left Atrial Appendage Suture Delivery Device

ACC prepares to launch two afib-related registry programs

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

Good Samaritan Hospital Offers an Alternative to Long-Term Warfarin Medication for Atrial Fibrillation with Newly Approved Watchman™ LAAC Implant

University of Michigan Health System among first in nation to use new device for stroke prevention

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content